ABP 501 BIOSMILAR TO ADALIMUMAB: FINAL SAFETY, IMMUNOGENICITY, AND EFFICACY RESULTS FROM AN OPEN-LABEL EXTENSION STUDY

被引：7
|
作者：
Cohen, S. [1 ]
Pablos, J. L. [2 ]
Wang, H. [3 ]
Mueller, G. A. [4 ]
Kivitz, A. [5 ]
Matsumoto, A. [6 ]
Krishnan, E. [3 ]
机构：
[1] Metroplex Clin Res Ctr, Dallas, TX USA
[2] Inst Invest Hosp, Madrid, Spain
[3] Amgen Inc, Thousand Oaks, CA USA
[4] Abt Nephrol & Rheumatol, Gottingen, Germany
[5] Altoona Ctr Clin Res, Duncansville, PA USA
[6] Arthrit & Rheumatism Associates, Wheaton, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3288
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0171
引用
收藏
页码：834 / 835
页数：2
相关论文
共 50 条
  • [11] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Alan Kivitz
    Alvin F. Wells
    Juan I. Vargas
    Herbert S. B. Baraf
    Maureen Rischmueller
    Justin Klaff
    Nasser Khan
    Yihan Li
    Kyle Carter
    Alan Friedman
    Patrick Durez
    Rheumatology and Therapy, 2023, 10 : 901 - 915
  • [12] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Kivitz, Alan
    Wells, Alvin F. F.
    Vargas, Juan I. I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 901 - 915
  • [13] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
    Kivitz, Alan
    Wells, Alvin F.
    Vargas, Juan I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    RHEUMATOLOGY, 2023, 62
  • [14] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
    Kivitz, A.
    Wells, A. F.
    Vargas, J. Ignacio
    Baraf, H. S. B.
    Rischmueller, M.
    Klaff, J.
    Khan, N.
    Li, Y.
    Carter, K.
    Friedman, A.
    Durez, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 620 - 621
  • [15] Long-term efficacy and safety of switching from adalimumab to risankizumab: results from the open label extension LIMMitless
    Reich, Kristian
    Ryan, Caitriona
    Crowley, Jeffrey
    Szepietowski, Jacek C.
    Zeng, Jiewei
    Valdes, Joaquin
    Photowala, Huzefa
    Kaufmann, Christian
    Gooderham, Melinda
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 19 - 20
  • [16] Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
    Strober, Bruce E.
    Poulin, Yves
    Kerdel, Francisco A.
    Langley, Richard G.
    Gu, Yihua
    Gupta, Shiraz R.
    Okun, Martin M.
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (04) : 671 - 681
  • [17] Efficacy and safety of lurasidone in adolescents with schizophrenia: Results of a 2-year, open-label extension study
    Goldman, R.
    Correll, C.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S88 - S89
  • [18] EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S160 - S160
  • [19] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Cabell, Chris H.
    Naik, Snehal U.
    Klassen, Preston
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
  • [20] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
12345